DIM — Sartorius Stedim Biotech SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual balance sheet for Sartorius Stedim Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	46.9	70.6	237	133	133
Net Total Accounts Receivable
Net Total Receivables	232	263	371	419	334
Total Inventory
Total Other Current Assets
Total Current Assets	636	874	1,456	1,671	1,415
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	550	644	928	1,292	1,633
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,845	2,857	3,951	5,065	7,740
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	428	568	1,037	1,036	937
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	687	1,419	2,295	2,616	5,102
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,159	1,438	1,656	2,449	2,638
Total Liabilities & Shareholders' Equity	1,845	2,857	3,951	5,065	7,740
Total Common Shares Outstanding